Article info

Download PDFPDF
Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma
  1. Correspondence to Dr Thomas Knösel, Institute of Pathology, Friedrich-Schiller University, Ziegelmühlenweg 1, 07743 Jena, Germany; thomas.knoesel{at}med.uni-jena.de
View Full Text

Citation

Hamidov Z, Altendorf-Hofmann A, Chen Y, et al
Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma

Publication history

  • Accepted June 9, 2011
  • First published July 1, 2011.
Online issue publication 
October 22, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.